Market Overview

UPDATE: Barrington Reiterates Outperform Rating, $650 PT on Intuitive Surgical

Share:
Related ISRG
The MedTech Group: 2017 Top Picks And Catalysts
Benzinga's Top Upgrades, Downgrades For January 4, 2017
Intuitive's Preliminary Q4'16 Results Indicate A Healthy Growth In da Vinci Procedural Volumes (Seeking Alpha)

In a report published Friday, Barrington reiterated its Outperform rating and $650.00 price target on Intuitive Surgical (NASDAQ: ISRG).

Barrington noted, “We are reiterating our OUTPERFORM rating and $650 price target following ISRG's Q4/12 earnings as we believe management will continue to execute on its significant market opportunities over the short and long term and will drive strong procedure growth/pricing power with new technologies in new procedures. We believe the short reports circulated recently are largely based on unfounded concerns and we expect the patient and hospital demand for da Vinci procedures to remain high in the face of the issues highlighted in those reports.”

Intuitive Surgical closed on Thursday at $576.07.

Latest Ratings for ISRG

DateFirmActionFromTo
Jan 2017Evercore ISI GroupDowngradesBuyHold
Oct 2016Wells FargoInitiates Coverage OnOutperform
Aug 2016Raymond JamesInitiates Coverage onOutperform

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: BarringtonAnalyst Color Reiteration Analyst Ratings

 

Related Articles (ISRG)

View Comments and Join the Discussion!